Perkins Capital Management Inc Buys Better Choice Co Inc, Sharps Compliance Corp, Aziyo Biologics Inc, Sells CareDx Inc, Cardiovascular Systems Inc, Chembio Diagnostics Inc

• New Purchases: BTTR, SMED, MIRO, IINN, BP, DGX, MTNB,
• Added Positions: AZYO, INUV, OOMA, PFE, XGN, GILD, CSLT, NBSE, AMRN,
• Reduced Positions: CDNA, CSII, RMTI, VCEL, ISR, ATEC, VVOS, STRM, OPRX, BLFS, CTLP, T, ACHV, NXPI, QLGN,
• Sold Out: CEMI, IIN, ITMR, LUMN, FLXN,

For the details of PERKINS CAPITAL MANAGEMENT INC's stock buys and sells, go to https://www.gurufocus.com/guru/perkins+capital+management+inc/current-portfolio/portfolio

1. OptimizeRx Corp (OPRX) - 115,180 shares, 6.10% of the total portfolio. Shares reduced by 1.07%
2. NeoGenomics Inc (NEO) - 157,750 shares, 4.71% of the total portfolio. Shares reduced by 0.35%
3. Natera Inc (NTRA) - 62,400 shares, 4.31% of the total portfolio. Shares reduced by 0.08%
4. IDEXX Laboratories Inc (IDXX) - 11,105 shares, 4.28% of the total portfolio.
5. Veracyte Inc (VCYT) - 124,980 shares, 3.59% of the total portfolio.

Perkins Capital Management Inc initiated holding in Better Choice Co Inc. The purchase prices were between $3 and $4.69, with an estimated average price of $3.83. The stock is now traded at around $3.870000. The impact to a portfolio due to this purchase was 0.67%. The holding were 290,500 shares as of 2021-09-30.

Perkins Capital Management Inc initiated holding in Sharps Compliance Corp. The purchase prices were between $8.27 and $10.34, with an estimated average price of $9.31. The stock is now traded at around $8.220000. The impact to a portfolio due to this purchase was 0.6%. The holding were 118,000 shares as of 2021-09-30.

Perkins Capital Management Inc initiated holding in Miromatrix Medical Inc. The purchase prices were between $6.6 and $12.75, with an estimated average price of $9.44. The stock is now traded at around $9.330000. The impact to a portfolio due to this purchase was 0.2%. The holding were 47,220 shares as of 2021-09-30.

Perkins Capital Management Inc initiated holding in Inspira Technologies Oxy BHN Ltd. The purchase prices were between $2.68 and $5.2, with an estimated average price of $3.67. The stock is now traded at around $2.350000. The impact to a portfolio due to this purchase was 0.15%. The holding were 92,000 shares as of 2021-09-30.

Perkins Capital Management Inc initiated holding in Quest Diagnostics Inc. The purchase prices were between $132.95 and $158, with an estimated average price of $146.26. The stock is now traded at around $145.010000. The impact to a portfolio due to this purchase was 0.13%. The holding were 1,475 shares as of 2021-09-30.

Perkins Capital Management Inc initiated holding in BP PLC. The purchase prices were between $23.09 and $27.33, with an estimated average price of $25.08. The stock is now traded at around $29.710000. The impact to a portfolio due to this purchase was 0.13%. The holding were 7,650 shares as of 2021-09-30.

Perkins Capital Management Inc added to a holding in Aziyo Biologics Inc by 47.92%. The purchase prices were between $6.75 and $9.52, with an estimated average price of $8.18. The stock is now traded at around $5.500000. The impact to a portfolio due to this purchase was 0.32%. The holding were 228,425 shares as of 2021-09-30.

Perkins Capital Management Inc added to a holding in NeuBase Therapeutics Inc by 41.89%. The purchase prices were between $3.27 and $4.76, with an estimated average price of $3.84. The stock is now traded at around $3.930000. The impact to a portfolio due to this purchase was 0.01%. The holding were 21,000 shares as of 2021-09-30.

Perkins Capital Management Inc sold out a holding in Chembio Diagnostics Inc. The sale prices were between $2.06 and $5.34, with an estimated average price of $2.77.

Perkins Capital Management Inc sold out a holding in IntriCon Corp. The sale prices were between $17.5 and $24, with an estimated average price of $21.55.

Perkins Capital Management Inc sold out a holding in Itamar Medical Ltd. The sale prices were between $16.67 and $30.4, with an estimated average price of $22.12.

Perkins Capital Management Inc sold out a holding in Lumen Technologies Inc. The sale prices were between $11.34 and $13.74, with an estimated average price of $12.55.

Perkins Capital Management Inc sold out a holding in Flexion Therapeutics Inc. The sale prices were between $4.4 and $8.2, with an estimated average price of $6.26.